Industry: Pharmaceuticals, Biotechnology
Fazix is a biotechnology company that relies on its novel lead design platform to accelerate drug discovery. Our core technology attributes to a proprietary de novo compound design algorithm that efficiently identifies drug candidates toward target structures. Leveraging our forte in computational chemistry, we offer our expertise in target binding site elucidation and structure-based drug design to the biopharmaceutical community. Compared with other rational drug design approaches, the Fazix technology offers many advantages: True de novo rational drug design based on first principles, not simply docking of existing structures or in silico screening. Extremely rapid design of compounds novel structures typically available in one ( www.fazix.com )
Fazix Corporation
Audubon Business & Technology Center 3960 Broadway
New York, New York 10032
USA
Tel: (212) 543-9696
Fax: (212) 543-9229